Mark Reding, MD

Medical Title:

Academic Appointments:


Clinical Interests:

Languages Spoken:


Board Certifications:

"Best Doctors for Women" Minnesota Monthly Magazine 2013

Mpls. St. Paul Magazine
"Top Doctor" - (2012, 2014)

U.S. News & World Report 2012 Top Doctor 

Kren BT, Unger GM, Sjeklocha L, Korman V, Diethelm-Okita BM, Reding MT, Steer CJ. Nanocapsule-delivered Sleeping Beauty mediates therapeutic factor VIII expression in liver sinusoidal epithelial cells of hemophilia A mice. J Clin Invest 2009 Jul; 119(7): 2086-99.

Astermark J, Lacroix-Desmazes S, Reding MT. Inhibitor development. Haemophilia 2008 Jul; 14(Suppl 3):36-42.

Elimelakh M, Dayton V, Park KS, Gruessner AC, Sutherland D, Howe RB, Reding MT, Eastlund T, van Burik JA, Singleton TP, Gruessner RW, Key NS. Red cell aplasia and autoimmune hemolytic anemia following immunosuppression with alemtuzumab, mycophenolate, and daclizumab in pancreas transplant recipients. Haematologica 2007; 92(8):1029-36.

Reding MT. Immunological aspects of inhibitor development. Haemophilia 2006 Dec; 12(Suppl 6):30-6.; (5) Berntorp E, Shapiro A, Astermark J, Blanchette VS, Collins PW, Dimichele D, Escuriola C, Hay CR, Hoots, WK, Leissinger CA, Negrier C, Oldenburg J, Peerlinck K, Reding MT, Hart C. Inhibitor treatment in haemophilias A and B: summary statement for the 2006 international consensus conference. Haemophilia 2006 Dec; 12(Suppl 6):1-7.

Discrimination is Against the Law. We comply with applicable Federal civil rights laws. We do not discriminate against, exclude or treat people differently because of race, color, national origin, age, disability or sex.
 Visit Other Fairview Sites 
(c) 2017 Fairview Health Services. All rights reserved.